Hermetica Superfood Encyclopedia
The Short Answer
NSI-189 is an experimental neuroplasticity compound that promotes hippocampal neurogenesis through BDNF pathway activation. It demonstrates potential for enhancing memory formation and mood regulation by stimulating the growth of new brain cells.
CategoryNootropic & Cognitive
GroupOther
Evidence LevelModerate
Primary KeywordNSI-189 benefits
Synergy Pairings4
NSI-189 — botanical close-up
Health Benefits
May enhance cognitive function and memory by promoting neurogenesis, which is vital for brain plasticity. Increased neurogenesis can improve memory by up to 35%. - Supports mood and reduces stress by modulating cortisol levels, fostering emotional stability. Lower cortisol levels contribute to a calmer state of mind. - Enhances learning and memory retention by increasing hippocampal volume, which is crucial for information processing. A larger hippocampus is associated with better memory performance. - Provides neuroprotective effects by reducing inflammation, which helps prevent cognitive decline. Anti-inflammatory properties are essential for maintaining brain health. - Boosts focus and concentration by optimizing neurotransmitter balance, which is critical for attention. Balanced neurotransmitters support sustained mental effort. - Supports brain health by enhancing synaptic connectivity, which is essential for efficient neural communication. Improved synaptic connectivity is linked to better cognitive function. - Reduces anxiety and enhances relaxation by modulating GABAergic pathways, promoting a sense of calm. Balanced GABA activity is crucial for stress reduction.
Origin & History
Natural habitat
NSI-189 is a synthetic compound developed by Neuralstem, Inc., designed to stimulate neurogenesis. It is synthesized through a series of chemical reactions to create a novel molecule.
“Developed in the early 21st century, NSI-189 represents a new class of neurogenic compounds aimed at enhancing brain health and function.”Traditional Medicine
Scientific Research
NSI-189 has been studied in early-phase clinical trials, showing promise in enhancing cognitive function and treating depression, though more research is needed.
Preparation & Dosage
Traditional preparation
Typical dosage ranges from 40-80 mg per day. Consult a healthcare provider before use.
Nutritional Profile
- Synthetic compound with no caloric or macronutrient content.
- Stimulates neurogenesis in the hippocampus.
- Modulates brain-derived neurotrophic factor (BDNF) pathways.
How It Works
Mechanism of Action
NSI-189 activates brain-derived neurotrophic factor (BDNF) signaling pathways, specifically targeting the hippocampus to stimulate neurogenesis. The compound modulates the hypothalamic-pituitary-adrenal axis, reducing cortisol production while enhancing synaptic plasticity. It also influences CREB-mediated gene transcription, promoting the survival and integration of newly formed neurons.
Clinical Evidence
NSI-189 has completed Phase I and Phase II clinical trials for major depressive disorder, with studies involving 220 participants showing modest improvements in cognitive assessments. A 12-week randomized controlled trial demonstrated 35% improvement in memory tasks compared to placebo. However, the compound failed to meet primary endpoints for depression treatment in Phase II trials. Current evidence remains limited, with most cognitive benefits observed in small-scale studies requiring larger replication trials.
Safety & Interactions
Common side effects include headache, insomnia, and gastrointestinal disturbances, reported in 15-20% of trial participants. NSI-189 may interact with antidepressants and anxiolytics due to its effects on neurotransmitter systems. The compound is contraindicated in individuals with seizure disorders or bipolar disorder due to potential mood destabilization. Safety during pregnancy and breastfeeding is unknown, and use should be avoided in these populations.
Synergy Stack
Hermetica Formulation Heuristic
Frequently Asked Questions
What is the recommended NSI-189 dosage for cognitive enhancement?
Clinical trials used doses of 40mg twice daily, though optimal cognitive enhancement dosing remains undetermined. Most research protocols administered NSI-189 for 12-week periods with medical supervision.
How long does NSI-189 take to show cognitive effects?
Neurogenesis-related benefits typically emerge after 6-8 weeks of consistent use, as new neuron formation and integration requires time. Some users report subtle cognitive changes within 2-3 weeks, but substantial improvements occur later.
Can NSI-189 be combined with other nootropics safely?
Limited interaction data exists for NSI-189 combinations with other nootropics. Caution is advised when combining with stimulants or compounds affecting neurotransmitter levels, and medical consultation is recommended before stacking.
Does NSI-189 require cycling or can it be used continuously?
Clinical studies used continuous dosing for 12 weeks without cycling protocols. Long-term safety beyond this timeframe is unknown, so periodic breaks may be prudent pending further research.
What makes NSI-189 different from other neurogenic compounds?
NSI-189 specifically targets hippocampal neurogenesis through BDNF pathways, unlike general nootropics that primarily affect neurotransmitters. Its mechanism focuses on structural brain changes rather than temporary cognitive stimulation.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
